Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Comparative Analysis of Actual Cost and Indonesian Case-Based Groups Rate in Inpatient Suspect of Acute Hepatitis of Unknown Aetiology.

Created on 14 Aug 2026

Authors

Siti Maemun, Aninda Dinar Widiantari, Nur Aliza, Vivi Setiawaty, Lhuri Dwianti Rahmartani

Published in

The Malaysian journal of medical sciences : MJMS. Volume 33. Issue 1. Pages 145-154. Epub Feb 28, 2026.

Abstract

Hospitals are crucial in implementing the referral and National Health Insurance (NHI) systems. The reimbursement structure by the Social Security Administrator for Health (SSAH) relies on the Indonesian Case-Based Groups (INA-CBG) method. This study aims to discern the variance between hospital inpatient costs and the corresponding inpatient INA-CBG rates, specifically for patients with suspected acute hepatitis of unknown aetiology (AHUA).
This research used a descriptive cross-sectional method. We compared the actual hospitalisation cost and INA-CBG's tariff in an Indonesian tertiary hospital from July to December 2022. The study encompasses patients with AHUA and uses a saturation sampling method.
Of the 17 patients suspected of AHUA, 16 made payments through NHI. A comprehensive analysis reveals that the total hospital costs based on INA-CBG rates show a deficit of IDR 21,604,464, reflecting a difference of 13.96%. The primary diagnoses among patients vary, with presentations of a combination of viral, bacterial, and parasitic infections alongside bile or liver disorders. The hospital incurred losses from services rendered to 10 patients. Notably, the significant allocations of hospital costs include laboratory (46.84%), pharmacy (19.01%), and accommodation (17.28%).
To maintain effective cost control in inpatient services, the focus should prioritise medical appropriateness, explicitly referencing Clinical Practice Guidelines (CPG) and Clinical Pathways.

PMID:
42598647
Bibliographic data and abstract were imported from PubMed on 14 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement